Alex11

The official paper for the pig trial is in peer review -stage, and has not been published yet. This is most likely the reason for the confidentiality of some details.

As far as I know, the dosages used in the Verteporfin studies at Stanford have not been published anywhere. Even in the detailed dissertation by Talbott (https://stacks.stanford.edu/file/druid:rp239gf7751/Talbott HE Dissertation-augmented.pdf), only discussions concerning concentrations (e.g. 2 mg/mL) are being made, with no mentioning of volumes injected (i.e. the dosages). You wrote: "This means we are very close to the optimal dosage. 0.4mg per cm2 is close to 2mg used for 5cm.". Could you please clarify the source for this claim.

No. As you probably know, the causes of these abnormal autoimmune responses are generally unknown. Let's keep this thread focused on Dr. Barghouthi's trials. Feel free to contact me in private. 🙂

Scarring alopecia trials would provide tremendous insight for both the fields of scar revisions and hair restoration. Diagnosed with lichen planopilaris (now inactive/burnt out), I'm closely following this development!

Thank you so much Dr Barghouthi for your effort - I'm so glad and relieved to hear from you again, and hope that you and your family are doing well. As someone suffering from scarring alopecia (lichen planopilaris), do you think it could be possible to achieve regrowth in scarred bald patches by performing e.g. FUE punches accompanied by Verteporfin injections in these areas, without actually transferring hair follicles from the donor area?